AngioDynamics
ANGO
156 hedge funds and large institutions have $376M invested in AngioDynamics in 2023 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 71 increasing their positions, 44 reducing their positions, and 20 closing their positions.
61% more repeat investments, than reductions
Existing positions increased: 71 | Existing positions reduced: 44
15% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 20
2% more funds holding
Funds holding: 153 → 156 (+3)
0% less capital invested
Capital invested by funds: $377M → $376M (-$1.83M)
1.63% less ownership
Funds ownership: 93.31% → 91.68% (-1.6%)
65% less call options, than puts
Call options by funds: $18K | Put options by funds: $52K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$5.23M |
| 2 |
AI
Acuitas Investments
Seattle,
Washington
|
+$3.58M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$3.09M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$2.09M |
| 5 |
JP Morgan Chase
New York
|
+$1.88M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$23.4M |
| 2 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$3.67M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$3.47M |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$2.87M |
| 5 |
State Street
Boston,
Massachusetts
|
-$2.73M |
ANGO Hedge Fund Activity: Q2 2023 in Review
156 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q2 2023, worth a combined $376M — down 0.48% from $377M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new ANGO positions and 20 closed out — a net gain of 3 holders — while 71 added to existing stakes and 44 trimmed.
The largest buyer was Soleus Capital Management, adding an estimated $5.23M. The largest seller was Victory Capital Management, cutting an estimated $23.4M.
- 156 institutional investors held AngioDynamics (ANGO) as of Q2 2023, up from 153 in Q1 2023.
- Funds reported $376M of AngioDynamics stock for Q2 2023, down 0.48% quarter-over-quarter.
- 23 funds opened new AngioDynamics positions in Q2 2023 and 20 closed out, a net change of +3 holders.
- The largest AngioDynamics buyer in Q2 2023 was Soleus Capital Management, an estimated $5.23M added.
- The largest AngioDynamics seller in Q2 2023 was Victory Capital Management, an estimated $23.4M sold.
Based on aggregated 13F filings for Q2 2023.